Acyl dihydroxyacetone phosphate (acyl DHAP2) pathway is important for the biosynthesis of glycerolipids, especially glycerol ether lipids (l-3). Acyl DHAP and its ether analog, alkyl DHAP, are enzymatitally reduced by NADPH to form the corresponding sn-glycerol3-phosphate derivatives (4) (5) (6) . The reductions of both acyl DHAP and alkyl DHAP are probably catalyzed by the same enzyme, i.e., acyl/alkyl DHAP reductase (EC 1.1.1.101) (6) (7) (8) . Previously it was shown that this enzyme is present in all mammalian tissues analyzed and it is localized in the microsomal and mitochondrial fractions of these tissues (6) . However, the recent demonstration that in ' This work was supported by Grants NS-08841 and NS-15747 from the U. S. Public Health Service, National Institutes of Health. 'Abbreviations used: DHAP, dihydroxyacetone phosphate;
G-3-P, sn-glycerol 3-phosphate; DTT, dithiothreitol. rodent livers DHAP acyltransferase, the first enzyme of this pathway, is mainly localized in the peroxisomes (9) suggests that the reductase may also be localized in peroxisomes and not in mitochondria.
Preliminary evidence indicated that the reductase is indeed present in the peroxisomal fraction of liver (9) ; however, compared to the DHAP acyltransferase, relatively more reductase activity was found to be present in the microsomal fraction. This nonperoxisomal localization of the reductase is also evidenced by the finding that although DHAP acyltransferase is absent in the cultured skin fibroblasts and leukocytes of Zellweger cerebrohepatorenal syndrome patients (who lack peroxisomes), the reductase activity is almost normal (10) . This dual distribution naturally raises the question of whether or not the same enzyme is present in both peroxisomes and endoplasmic reticulum. Therefore, the subcellular distribution and the properties The distribution of the reductase in the guinea pig liver subcellular fraction shows that this enzyme is enriched in the "light mitochondrial"
and microsomal fractions ( Fig. 1) . In terms of total activity, the enzyme is found to be distributed in the mitochondrial(25% of total), light mitochondrial (35%), and microsomal (35%) fractions. In contrast, the distribution of DHAP acyltransferase, the first enzyme of this pathway, is 27% in the mitochondrial fraction, 59% in light mitochondrial, and 14% in the microsomes.
That most of the reductase activity present in the "light mitochondrial" fraction is indeed peroxisomal is shown by fractionating the "L" fraction by centrifugation through a metrizamide density gradient. In this gradient the peroxisomes are well separated from other organelles (16) to be associated mostly with the peroxisomal fractions (data not shown; however, see Fig. 2 ). In rat liver the reductase activity is also found to be present in both peroxisomes and microsomes. This is shown in Fig. 2 where the liver homogenate (minus the nuclear fraction) was subjected to a metrizamide density gradient centrifugation procedure. A portion of the reductase is seen to be sedimented with the DHAP acyltransferase and catalase indicating the peroxisomal localization of the reductase. About 58% of the reductase seems to be extraperoxisomal compared to only 33% of DHAP acyltransferase (Fig. 2) .
Properties of the Peroxisomal and Microsomal Acyl/Alkyl DHAP Reductase
The properties of the reductase in the guinea pig liver peroxisomal fraction and the microsomal fraction are studied in detail. It should be noted that though the peroxisomes used did not contain any glucase-6-phosphatase activity (microsomal marker enzyme), the microsomal fraction contained 10-12'S of the total cellular sedimentable catalase (marker enzyme for peroxisomes and microperoxisomes).
(a) pH optima. The activity of both the peroxisomal and microsomal enzymes was measured from pH 4.5 to pH 9.0 and the highest activity in both cases was found at pH 6.5 with a broad shoulder of activity up to pH 8.5. The activity is not influenced by buffer composition as fairly continuous pHversus-enzyme activity curves were obtained even though different buffers were used (Fig. 3A) . (6) Heat stability. Both the peroxisomal and microsomal reductases are fairly heat stable. As shown in Fig. 3B heating the enzyme at 5O"C, or even at 55"C, for 15 min did not diminish much of their activities. The heat stability of this enzyme in both these subcellular organelles is enhanced in the presence of the cosubstrate NADPH (Fig. 3B) been extensively used to study the topography of enzymes in vesicular membranes (26, 27) . When such experiments were done using the peroxisomal and microsomal fractions, it was found that the reductase in both the organelles is extremely labile toward treatment with trypsin in the presence or absence of the detergent Triton X-100 (Fig. 3C) . The enzyme remained stable when treated with Triton alone or when the trypsin was immediately neutralized by the addition of antitrypsin (Fig. 3C) . of sulfhydryl group inhibitors such as N-ethylmaleimide and DTNB. Thiols such as DTT do not have any effect on the membrane-bound enzymes but these agents increase the stability of the enzymes after solubilization from membranes. NADP+, a product, inhibits both the peroxisomal and microsomal enzymes (see later). As described by Coleman and Bell (28) , it was found that palmitoyl CoA at low concentration (10 pM) inhibited both the microsomal and peroxisomal enzyme to the same extent ('75%). The enzymes from both the subcellular organelles can be solubilized with detergents in the presence of high concentration of salt (KCl) and the solubilized enzyme(s) is stabilized by the addition of the cosubstrate NADPH [Ref. (7) and also Ghosh and Hajra (unpublished experiments)].
Kinetic Properties
Both the peroxisomal and microsomal reductases follow regular Michaelis-Menten kinetics when the NADPH concentrations are varied keeping the concentrations of alkyl DHAP and acyl DHAP a constant. The Km and V,, values obtained from such experiments are given in Table I . As described previously (6, 29) , NADH at high concentrations can also be utilized by the enzyme to reduce acyl DHAP or alkyl DHAP. The kinetic constants obtained by using NADH as a cosubstrate are given in Table I . Hyperbolic curves were also obtained when NADPH concentration was kept constant (66 PM) varying the concentrations of alkyl DHAP. However, in this case at high concentrations of alkyl DHAP deviations from linearity (reciprocal plot) were observed probably because of the inhibition of the enzyme by high concentrations of alkyl DHAP. The apparent Km of alkyl DHAP is given in Table I. NADP+ acts as a competitive inhibitor of NADPH for both the peroxisomal and microsomal enzymes. As shown in Fig. 4 , the apparent Km values of the enzymes for NADPH are increased in the presence of NADP+. The Ki values for NADP+ calculated from these results are 2.1 pM for the peroxisomal and 1.8 pM for the microsomal enzyme.
Efect of Feeding Clojibrate
A number of hypolipidemic drugs when fed to rodents cause a proliferation of peroxisomes in liver and induce a number of peroxisomal and microsomal enzymes (30, 31) . When mice were chronically fed clofibrate, a hypolipidemic drug, for 7 days an increase of 55-70s of the total liver acyl/ alkyl DHAP reductase was observed. As described previously (31) , the liver DHAP acyltransferase activity in these animals was increased by lOO-120% and the catalase activity by 50-70s. The distribution of the reductase between the peroxisomes and microsomes in mouse liver is similar to those found in guinea pig and rat liver. The increase in activity of the reductase after clofibrate administration is found to be similar (160% of the control) in both the microsomal and peroxisomal fractions (Table II) . A single time-course experiment indicates that there was an equal rate of increase in the activity of the enzyme in microsomal and peroxisomal fractions from Day 1 to Day 5 after which the activities reached a plateau of 170% of normal controls.
DISCUSSION
Results presented here indicate that the acyl/alkyl DHAP reductase has a dual subcellular distribution in liver. If it is assumed that particulate-bound catalase is the marker enzyme for peroxisomes and glucose-6-phosphatase is the marker enzyme for microsomes, then it can be calculated from the data presented in Figs. 1 and 2 that 65-70s of the reductase is in peroxisomes and 30-35s in microsomes. However, these estimates may not be accurate because the microsomal fraction may contain membrane fragments of peroxisomes which contains no catalase and also the microperoxisomes with unknown amounts of catalase. In this respect membrane-bound DHAP acyltransferase probably would be a better marker enzyme for peroxisomes and microperoxisomes. In comparison to the DHAP acyltransferase, the liver microsomal fraction contains 20-25% more of acyl/alkyl DHAP reductase.
In both peroxisomes and microsomes the reductase activity was lost after a brief trypsin treatment, indicating that the enzyme is exposed to the cytosolic side of the membrane. This is in contrast to the topography of DHAP acyltransferase which, from a similar kind of experiment, is postulated to be present in the luminal side of the peroxisomal and microsomal vesicles membranes (27, 32) . This indicates that the acyl DHAP synthesized inside the peroxisomes is transported out and is reduced by the cytosolic NADPH. Therefore, our previous assumption (33) that in the acyl DHAP pathway the 3H from D-[~-~H]-or D- [3-3H] glucose is incorporated via NADPH at the C-2 position of glycerolipid appears to be valid.
Besides the topological similarities, both the microsomal and the peroxisomal enzymes have similar properties with respect to the pH optimum, heat stability, substrate specificity, inhibition by NADP+, and kinetic properties. Therefore, it may be concluded that the same enzyme is present in both these organelles. The minor quantitative differences in the kinetic constants of the enzyme in peroxisomes and microsomes (Table I ) may be due to the different environment of the enzyme in these two different membranes. Not many enzymes common to these two organelles are described in the literature.
The only other example is carnitine acetyltransferase which has been well studied by Bieber, Tolbert, and co-workers (34, 35) . Though carnitine acetyltransferase is soluble in peroxisomes and membrane bound in microsomes, it has been postulated from the similarities in properties that the same enzyme exists in both these organelles (35) .
The presence of the same enzyme in peroxisomes and in endoplasmic reticulum raises some interesting questions regarding the biogenesis of this protein. From morphological evidence it was assumed that peroxisomes originate by budding off from endoplasmic reticulum (36, 37) . However, in recent years Lazarow and co-workers in an extensive series of investigations provided evidence that the peroxisomal soluble and membrane-bound proteins are biosynthesized on the polysomes in cytosol and then are transferred to the peroxisomes (38, 39) . It is possible that the acyl/alkyl DHAP reductase, synthesized in cytosol, is transported to both the peroxisomes and endoplasmic reticulum. The equal rate of induction of this enzyme in peroxisomes and microsomes after clofibrate feeding supports this hypothesis. In Zellweger cerebrohepatorenal syndrome where peroxisomes are absent, all of the reductase is probably transported to the endoplasmic reticulum, thus resulting in the normal activity (10). However, it is possible that the enzyme present in these two cellular compartments may not be exactly identical and minor differences exist between them so that these end up in the respective organelles. Only purifying the enzymes to homogeneity from these two different organelles and comparing their properties will clearly establish whether or not the same enzyme is present in peroxisomes and microsomes. Present work in this laboratory is directed toward this goal of purifying the acyl/alkyl DHAP reductase solubilized from peroxisomal and microsomal membranes.
